Logo image of PDEX

PRO-DEX INC (PDEX) Stock Fundamental Analysis

USA - NASDAQ:PDEX - US74265M2052 - Common Stock

34.49 USD
-0.27 (-0.78%)
Last: 9/19/2025, 12:19:07 PM
Fundamental Rating

4

PDEX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 191 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of PDEX get a neutral evaluation. Nothing too spectacular is happening here. PDEX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year PDEX was profitable.
In the past year PDEX has reported a negative cash flow from operations.
Of the past 5 years PDEX 4 years were profitable.
In multiple years PDEX reported negative operating cash flow during the last 5 years.
PDEX Yearly Net Income VS EBIT VS OCF VS FCFPDEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

The Return On Assets of PDEX (14.58%) is better than 95.81% of its industry peers.
Looking at the Return On Equity, with a value of 26.55%, PDEX belongs to the top of the industry, outperforming 96.86% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 19.83%, PDEX belongs to the top of the industry, outperforming 98.43% of the companies in the same industry.
PDEX had an Average Return On Invested Capital over the past 3 years of 11.81%. This is above the industry average of 8.46%.
The last Return On Invested Capital (19.83%) for PDEX is above the 3 year average (11.81%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 14.58%
ROE 26.55%
ROIC 19.83%
ROA(3y)9%
ROA(5y)12.39%
ROE(3y)15.75%
ROE(5y)22.01%
ROIC(3y)11.81%
ROIC(5y)13.41%
PDEX Yearly ROA, ROE, ROICPDEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

The Profit Margin of PDEX (14.61%) is better than 92.15% of its industry peers.
In the last couple of years the Profit Margin of PDEX has declined.
PDEX has a better Operating Margin (18.24%) than 89.53% of its industry peers.
PDEX's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 31.36%, PDEX is doing worse than 75.39% of the companies in the same industry.
PDEX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 18.24%
PM (TTM) 14.61%
GM 31.36%
OM growth 3Y3.8%
OM growth 5Y-6.22%
PM growth 3Y-37.56%
PM growth 5Y-23.7%
GM growth 3Y-8.87%
GM growth 5Y-5.57%
PDEX Yearly Profit, Operating, Gross MarginsPDEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

PDEX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
There is no outstanding debt for PDEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PDEX Yearly Shares OutstandingPDEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
PDEX Yearly Total Debt VS Total AssetsPDEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

PDEX has an Altman-Z score of 5.29. This indicates that PDEX is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 5.29, PDEX is doing good in the industry, outperforming 79.58% of the companies in the same industry.
A Debt/Equity ratio of 0.28 indicates that PDEX is not too dependend on debt financing.
PDEX has a Debt to Equity ratio of 0.28. This is comparable to the rest of the industry: PDEX outperforms 50.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Altman-Z 5.29
ROIC/WACC2.42
WACC8.19%
PDEX Yearly LT Debt VS Equity VS FCFPDEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

PDEX has a Current Ratio of 2.73. This indicates that PDEX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PDEX (2.73) is comparable to the rest of the industry.
A Quick Ratio of 1.45 indicates that PDEX should not have too much problems paying its short term obligations.
PDEX's Quick ratio of 1.45 is in line compared to the rest of the industry. PDEX outperforms 40.31% of its industry peers.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 1.45
PDEX Yearly Current Assets VS Current LiabilitesPDEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

2

3. Growth

3.1 Past

PDEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 309.68%, which is quite impressive.
Measured over the past years, PDEX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.96% on average per year.
EPS 1Y (TTM)309.68%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%-21.74%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%16.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PDEX Yearly Revenue VS EstimatesPDEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
PDEX Yearly EPS VS EstimatesPDEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.58, the valuation of PDEX can be described as correct.
Based on the Price/Earnings ratio, PDEX is valued cheaply inside the industry as 88.48% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.41, PDEX is valued rather cheaply.
A Price/Forward Earnings ratio of 14.21 indicates a correct valuation of PDEX.
Based on the Price/Forward Earnings ratio, PDEX is valued cheaply inside the industry as 87.43% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.88, PDEX is valued a bit cheaper.
Industry RankSector Rank
PE 13.58
Fwd PE 14.21
PDEX Price Earnings VS Forward Price EarningsPDEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PDEX is valued cheaply inside the industry as 93.19% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9
PDEX Per share dataPDEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PDEX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.24
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PDEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PRO-DEX INC

NASDAQ:PDEX (9/19/2025, 12:19:07 PM)

34.49

-0.27 (-0.78%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)09-04 2025-09-04/amc
Earnings (Next)10-29 2025-10-29
Inst Owners30.74%
Inst Owner Change12.8%
Ins Owners35.95%
Ins Owner Change0%
Market Cap112.44M
Analysts82.86
Price Target57.12 (65.61%)
Short Float %12.44%
Short Ratio5.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)64.21%
Min EPS beat(2)57.38%
Max EPS beat(2)71.05%
EPS beat(4)4
Avg EPS beat(4)77.71%
Min EPS beat(4)28.85%
Max EPS beat(4)153.55%
EPS beat(8)5
Avg EPS beat(8)9.49%
EPS beat(12)7
Avg EPS beat(12)15.5%
EPS beat(16)7
Avg EPS beat(16)5.1%
Revenue beat(2)1
Avg Revenue beat(2)7.88%
Min Revenue beat(2)-3.54%
Max Revenue beat(2)19.3%
Revenue beat(4)3
Avg Revenue beat(4)18.85%
Min Revenue beat(4)-3.54%
Max Revenue beat(4)38.97%
Revenue beat(8)6
Avg Revenue beat(8)10.51%
Revenue beat(12)10
Avg Revenue beat(12)13.77%
Revenue beat(16)12
Avg Revenue beat(16)10.76%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.08%
EPS NY rev (1m)0%
EPS NY rev (3m)22.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 13.58
Fwd PE 14.21
P/S 1.75
P/FCF N/A
P/OCF N/A
P/B 3.19
P/tB 3.19
EV/EBITDA 9
EPS(TTM)2.54
EY7.36%
EPS(NY)2.43
Fwd EY7.04%
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS19.67
BVpS10.82
TBVpS10.81
PEG (NY)N/A
PEG (5Y)1.24
Profitability
Industry RankSector Rank
ROA 14.58%
ROE 26.55%
ROCE 25.45%
ROIC 19.83%
ROICexc 25.27%
ROICexgc 25.29%
OM 18.24%
PM (TTM) 14.61%
GM 31.36%
FCFM N/A
ROA(3y)9%
ROA(5y)12.39%
ROE(3y)15.75%
ROE(5y)22.01%
ROIC(3y)11.81%
ROIC(5y)13.41%
ROICexc(3y)13.33%
ROICexc(5y)16.93%
ROICexgc(3y)13.36%
ROICexgc(5y)17.03%
ROCE(3y)15.15%
ROCE(5y)17.2%
ROICexcg growth 3Y11.8%
ROICexcg growth 5Y-12.49%
ROICexc growth 3Y11.98%
ROICexc growth 5Y-12.32%
OM growth 3Y3.8%
OM growth 5Y-6.22%
PM growth 3Y-37.56%
PM growth 5Y-23.7%
GM growth 3Y-8.87%
GM growth 5Y-5.57%
F-Score6
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Debt/EBITDA 0.76
Cap/Depr 102.36%
Cap/Sales 1.96%
Interest Coverage 16.27
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.73
Quick Ratio 1.45
Altman-Z 5.29
F-Score6
WACC8.19%
ROIC/WACC2.42
Cap/Depr(3y)140.73%
Cap/Depr(5y)342.39%
Cap/Sales(3y)2.61%
Cap/Sales(5y)6.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)309.68%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%-21.74%
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%16.43%
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y81.9%
EBIT growth 3Y16.56%
EBIT growth 5Y7.53%
EBIT Next Year103.08%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.3%
FCF growth 3YN/A
FCF growth 5Y22%
OCF growth 1Y-11.14%
OCF growth 3YN/A
OCF growth 5Y13.23%